A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...

NCT00923481 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Head and Neck Neoplasms
Pheochromocytoma
Colorectal Neoplasms
Carcinoma, Non-Small-Cell Lung
Carcinoma, Renal Cell

Interventions

DRUG: Fostamatinib disodium

Sponsor

National Cancer Institute (NCI)